ACCUSTEM SCIENCES, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-1.8M | $-1.5M | $-2.1M | $-3.7M | $-670.6K |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $418 | $3.6K | $3.6K | $3.3K | — |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $88.7K | $69.7K | $78.6K | $133.9K | $21.3K |
| Net Cash from Operating Activities | $-850.4K | $-664.1K | $-1.6M | $-1.8M | — |
| Investing Activities | |||||
| Capital Expenditures | — | — | — | $11.0K | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | $-11.0K | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $859.3K | $647.6K | $903.1K | $2.6M | — |
| Net Change in Cash | $8.9K | $-16.4K | $-712.5K | $734.0K | — |
| Free Cash Flow | — | — | — | $-1.8M | — |